We offer clients seven main categories of services:

JM HYDE PROGRAMS

Engineering

Process Design and Engineering

From the start of the design for a new facility to modification of an existing system, JM Hyde Consulting provides design and process systems integration services for biopharmaceutical and pharmaceutical facilities.

Areas of Expertise:

Equipment Engineering

  • Media Preparation
  • Cell culture
  • Upstream/Downstream processing

Facility Engineering

JM Hyde provides facility infrastructure project support for pilot and large scale manufacturing, which includes:

  • Basis of Design
  • P&IDs
  • Process Design Review
  • FAT/SAT Services
  • Maintenance/Spare parts programs
  • Hazard Analysis

Fill/Finish Engineering

  • Package development
  • Preclinical through Commercial

Cleaning Programs

JM Hyde Consulting is the world-wide leader in the design and implementation of pharmaceutical/biopharmaceutical cleaning processes and programs. We have designed and implemented cleaning programs resulting in licensing and approval for our clients.

Areas of Expertise

  • Clean In Place
  • Steam In Place

Services offered

  • Surveys and assessments of existing cleaning operations
  • Risk Assessment Analysis
  • Cleaning Equipment Engineering (CIP/SIP/COP)
  • Supportive Analytical Services
  • Customized Services such as
    • Contamination Root Cause Investigations/Prevention
    • Sterility Improvements Recommendations
    • SOP Development
    • Viral Inactivation Temperature Distribution Evaluation

Compliance and Validation Programs

Our goal is to provide our clients with high quality, cost-effective compliance and validation solutions for the manufacturing, processing, and distribution of drug products.

Expertise Areas:

  • Cleaning Validation
  • Strategic Validation Documentation
  • Integrated Commissioning and Qualification
  • Risk Based Compliance Management

JM Hyde's approach to compliance integrates our entire portfolio of services. Our knowledge and experience in the Pharmaceutical and Biopharmaceutical industry, as well as an in-depth understanding of the FDA's risk-based management approach, provides added value for our clients.